Siili Solutions Oyj
Siili Solutions Oyj - Managers' Transactions - Toropainen
Siili Solutions Oyj - Managers' Transactions - Toropainen
Siili Solutions Oyj - Managers' Transactions - Toropainen
Siili Solutions Plc Stock Exchange Release 23 October 2025 at 11.00 EEST
____________________________________________
Person subject to the notification requirement
Name: Tuomas Toropainen
Position: Chief Financial Officer
Issuer: Siili Solutions Oyj
LEI: 7437003WYXJUSV27Q316
Notification type: INITIAL NOTIFICATION
Reference number: 127468/5/4
____________________________________________
Transaction date: 2025-10-22
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000043435
Nature of transaction: ACQUISITION
Transaction details
(1): Volume: 25 Unit price: 4.77 EUR
(2): Volume: 222 Unit price: 4.75 EUR
(3): Volume: 669 Unit price: 4.75 EUR
(4): Volume: 9 Unit price: 4.75 EUR
(5): Volume: 529 Unit price: 4.75 EUR
(6): Volume: 416 Unit price: 4.75 EUR
(7): Volume: 68 Unit price: 4.735 EUR
(8): Volume: 68 Unit price: 4.735 EUR
(9): Volume: 68 Unit price: 4.735 EUR
(10): Volume: 68 Unit price: 4.735 EUR
(11): Volume: 149 Unit price: 4.735 EUR
(12): Volume: 217 Unit price: 4.82 EUR
(13): Volume: 413 Unit price: 4.815 EUR
(14): Volume: 198 Unit price: 4.8 EUR
(15): Volume: 255 Unit price: 4.8 EUR
(16): Volume: 500 Unit price: 4.8 EUR
(17): Volume: 412 Unit price: 4.85 EUR
(18): Volume: 203 Unit price: 4.8 EUR
(19): Volume: 236 Unit price: 4.8 EUR
(20): Volume: 400 Unit price: 4.76 EUR
(21): Volume: 300 Unit price: 4.83 EUR
Aggregated transactions (21):
Volume: 5425 Volume weighted average price: 4.78226 EUR
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Kitron ASA23.10.2025 13:42:32 CEST | Press release
Kitron: Allocation of options
Aduro Clean Technologies Inc.23.10.2025 13:00:00 CEST | Press release
Aduro Clean Technologies Advances Demonstration Plant Program with Extruder Engineering Trials
Amphista Therapeutics23.10.2025 13:00:00 CEST | Press release
Amphista Therapeutics announces three key strategic leadership appointments to drive transition of its Targeted Glue™ protein degraders into clinical development
George Medicines23.10.2025 13:00:00 CEST | Press release
TRIDENT, a dedicated stroke outcomes trial in patients with a history of intracerebral hemorrhage (ICH), demonstrates the potential advantages of intensive blood pressure treatment with low-dose triple combination therapyTRIDENT, a dedicate
Nykredit Realkredit A/S23.10.2025 12:27:51 CEST | Pressemeddelelse
Fastsættelse af kuponrenter - Nykredit Realkredit A/S
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom